Literature DB >> 2166546

Turnover of functional basic fibroblast growth factor receptors on the surface of BHK and NIH 3T3 cells.

D Moscatelli1, P Devesly.   

Abstract

The recovery of functional cell-surface bFGF receptors after trypsin treatment was studied in BHK cells and NIH 3T3 cells. Restoration of functional bFGF receptors occurred at an approximately linear rate with 50% of the high-affinity binding capacity restored after 4 hr. Restoration of functional receptors required protein synthesis but not RNA synthesis. Upon exposure of BHK cells to bFGF, cell-surface receptors were rapidly lost, with only 25% remaining after 1 hr. When the bFGF was removed, down-regulated BHK and NIH 3T3 cells recovered cell-surface receptors at about the same rate observed in trypsin-treated cells. The recovery of receptors after down-regulation was inhibited by protein synthesis inhibitors. Addition of the protein synthesis inhibitor cycloheximide to unperturbed cultures of BHK or NIH 3T3 cells resulted in a time-dependent loss of cell-surface bFGF receptors, demonstrating that the receptors turn over constantly in the absence of ligand. These results suggest that bFGF receptors do not recycle and must be continuously synthesized.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166546     DOI: 10.3109/08977199009037499

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  6 in total

1.  Fibroblast growth factor 2 induced proliferation in osteoblasts and bone marrow stromal cells: a whole cell model.

Authors:  Melissa A Dupree; Solomon R Pollack; Elliot M Levine; Cato T Laurencin
Journal:  Biophys J       Date:  2006-07-21       Impact factor: 4.033

2.  Fibroblast growth factor receptor-1 expression is associated with neointimal formation in vitro.

Authors:  S J Daley; A I Gotlieb
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

3.  FGF2 stimulation of the pyrophosphate-generating enzyme, PC-1, in pre-osteoblast cells is mediated by RUNX2.

Authors:  Nan E Hatch; Yan Li; Renny T Franceschi
Journal:  J Bone Miner Res       Date:  2009-04       Impact factor: 6.741

4.  Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition.

Authors:  E R Edelman; M A Nugent; M J Karnovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

5.  Phospholipase C release of basic fibroblast growth factor from human bone marrow cultures as a biologically active complex with a phosphatidylinositol-anchored heparan sulfate proteoglycan.

Authors:  G Brunner; J Gabrilove; D B Rifkin; E L Wilson
Journal:  J Cell Biol       Date:  1991-09       Impact factor: 10.539

6.  Endocytosis of Fgf8 is a double-stage process and regulates spreading and signaling.

Authors:  Charanya Rengarajan; Alexandra Matzke; Luisa Reiner; Véronique Orian-Rousseau; Steffen Scholpp
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.